Abstract
Peritoneal dialysis is an important therapeutic option for patients with chronic kidney disease (CKD) in the terminal stage. However, during the treatment, this therapy presents the development of peritoneal inflammation and fibrosis due to several factors, including the incompatibility of solutions, with its high concentration of glucose the main determinant of the activation of the infl…